What he's saying is that we're not like a drug company. With a drug company there can be a lot of uncertainty about whether a drug will pass or fail a clinical trial. The general parameter is the p-value, a statistical determination of the probability that a drug is effective for a patient outcome that is monitored by the trial. If a p-value is below 0.05 then the drug failed. So there's a lot of risk and nervousness waiting for drug trial results as I've experienced many times.
The DurAVR, and medical devices in general, don't have such strict rules about pass or fail and the DurAVR has shown in the patients already implanted that everything looks real good. So that's why Wayne is saying it's de-risked. The DurAVR will eventually be approved it just will take time and money.
- Forums
- ASX - By Stock
- AVR
- Ann: Latest Patient Group Show Best Results to Date at 30 Days
Ann: Latest Patient Group Show Best Results to Date at 30 Days, page-83
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$12.49 |
Change
0.490(4.08%) |
Mkt cap ! $264.0M |
Open | High | Low | Value | Volume |
$12.11 | $12.49 | $11.50 | $155.8K | 13.16K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 175 | $11.81 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.49 | 77 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 772 | 11.600 |
2 | 2000 | 11.500 |
1 | 80 | 11.250 |
1 | 500 | 11.050 |
2 | 600 | 11.000 |
Price($) | Vol. | No. |
---|---|---|
12.490 | 77 | 1 |
12.500 | 56 | 1 |
12.520 | 500 | 1 |
12.850 | 99 | 1 |
13.300 | 200 | 1 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |